Moderna stock jumps on planned national cancer vaccine effort
Moderna stock popped 14% on Friday following a report on efforts to accelerate cancer vaccine development, lifting other biotech shares.
Moderna stock popped 14% on Friday following a report on efforts to accelerate cancer vaccine development, lifting other biotech shares.